Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Commitment to partnership and joint innovation for cell and gene therapies
Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.
Irish Examiner, 21 june 2021
Hovione commitment to setting SBTs in line with the Paris Agreement
Google Chrome
Safari
Firefox
Edge